Assignee
ASPIRA WOMENS HEALTH INC
US·1 granted patent·7 pending applications·0 citations·filing 2017–2025
Top patents by PatentIndex Score
8 records- 0172US2022317126A1Biomarkers for ovarian cancer ctap3-related proteinsASPIRA WOMENS HEALTH INC·Filed 2021·Application pending·0 cites
- 0269US2025237655A1Biomarkers for ovarian cancerASPIRA WOMENS HEALTH INC·Filed 2024·Application pending·0 cites
- 0362US11255857B2Biomarkers for ovarian cancer CTAP3-related proteinsASPIRA WOMENS HEALTH INC·Filed 2017·Granted Feb 22, 2022·0 cites·6 claims
- 0460US2021181207A1Biomarkers for Ovarian Cancer: B2 MicroglobulinASPIRA WOMENS HEALTH INC·Filed 2020·Application pending·0 cites
- 0552US2023127069A1Compositions for ovarian cancer assessment having improved specificity and sensitivityASPIRA WOMENS HEALTH INC·Filed 2022·Application pending·0 cites
- 0644US2023086542A1Compositions for endometriosis assessment having improved specificityASPIRA WOMENS HEALTH INC·Filed 2021·Application pending·0 cites
- 0742US2025290933A1Compositions for endometriosis assessment having improved specificityASPIRA WOMENS HEALTH INC·Filed 2025·Application pending·0 cites
- 0841US2021215701A1Compositions for ovarian cancer assessmentASPIRA WOMENS HEALTH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASPIRA WOMENS HEALTH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →